Panel Discussion 01
What Gets Funded Now: How APAC MedTech Startups Can Win in a More Selective Environment
As investment becomes more selective,
founders need to demonstrate stronger
clinical evidence, commercial validation
and disciplined milestone planning.
Colin Tan of Coronet Ventures,
Dr Anand Govindaluri of Govin Capital,
and Dexter Tiah of NUS Enterprise
shared perspectives on investor
expectations, capital efficiency,
traction and risk reduction.

